• Generated $1.1M in revenue in Q3-FY2021 (quarter end April 30, 2021), up 24% YoY, and up 8.6% QoQ. 98% of revenue came from dried flower sales. Revenue was significantly below our expectations as the company has yet to start generating meaningful revenue from its 2.0 products (edibles and beverages).

      • To read more about THC BioMed Intl Ltd. click below on downloads

Visit THC BioMed Intl Ltd. page for more research, discussion boards and to like, and share.

Are you enjoying the highlights?

Discover the company's fair value estimate from our certified analysts, identify potential risks, and explore exciting upcoming catalysts in our detailed report.

Already a member? Sign In

Investors are also interested in: